Stcube Inc
052020
Company Profile
Business description
Stcube Inc is a biopharmaceutical company, develops therapies to treat novel immune evasion mechanisms in cancer in Korea.
Contact
No.2201, Korea World Trade Center Trade Tower
511, Yeongdong-daero
Samsung-dong
Gangnam-gu
Seoul06164
KORT: +82 25513370
Sector
Technology
Stock type
Sensitive
Industry
Electronics & Computer Distribution
Fiscal Year End
31 December 2025
Employees
16
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,723.50 | 17.90 | -0.20% |
| CAC 40 | 7,592.96 | 39.51 | 0.52% |
| DAX 40 | 23,259.28 | 201.90 | 0.88% |
| Dow JONES (US) | 42,171.66 | 44.14 | -0.10% |
| FTSE 100 | 8,830.72 | 38.92 | 0.44% |
| HKSE | 23,530.48 | 292.74 | 1.26% |
| NASDAQ | 19,546.27 | 25.18 | 0.13% |
| Nikkei 225 | 38,403.23 | 85.11 | -0.22% |
| NZX 50 Index | 12,569.05 | 58.27 | -0.46% |
| S&P 500 | 5,980.87 | 1.85 | -0.03% |
| S&P/ASX 200 | 8,505.50 | 18.20 | -0.21% |
| SSE Composite Index | 3,359.90 | 2.21 | -0.07% |